Market revenue in 2023 | USD 93.9 million |
Market revenue in 2030 | USD 155.4 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Meibomian gland expression (mgx) |
Fastest growing segment | Combination (MGX+IPL) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Broadband light (BBL), Intense Pulsed Light (IPL), Meibomian Gland Expression (MGX), Combination (MGX+IPL) |
Key market players worldwide | Sight Sciences Inc, Lumenis, Johnson & Johnson, Alcon Inc, MiBo Medical Group, ESW vision |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye treatment devices market will help companies and investors design strategic landscapes.
Meibomian gland expression (mgx) was the largest segment with a revenue share of 41.21% in 2023. Horizon Databook has segmented the U.S. dry eye treatment devices market based on broadband light (bbl), intense pulsed light (ipl), meibomian gland expression (mgx), combination (mgx+ipl) covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of Dry Eye Diseases (DED) in the U.S. continues to grow at a rapid pace, creating an increased demand for advanced and effective therapies. According to an article published in the NCBI, the prevalence of DED is approximately 6.8% of the adult population in the U.S. or around 16 million diagnosed cases.
The prevalence is higher in females as compared to males. Nearly 60% of patient visits to eye care providers are due to DED. The increasing incidence of risk factors, such as systemic diseases (diabetes), high digital device usage, and a growing aging population, is anticipated to further increase the burden of DED in the U.S.
The strengthening presence of prominent market players such as J&J Vision, Sight Sciences, Alcon, and Mi Bo Medical Group in the U.S. has contributed to the country’s leading market share. The presence of key players ensures rapid availability of advanced technologies in the region. For instance, the novel blink assisted thermal technology, Tear Care, was commercialized first in the U.S.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. dry eye treatment devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. dry eye treatment devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account